Tomáš Mrkvan
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Immunology top 5%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Papers in
- Epidemiology 14
- Herpesvirus Infections and Treatments 7
- Pneumonia and Respiratory Infections 5
- Biomaterials 10
- Nanoparticle-Based Drug Delivery 10
- Co-authors
- Blanka Řı́hová (14 shared papers)Karel Ulbrich (14 shared papers)Tomáš Etrych (11 shared papers)Petr Chytil (7 shared papers)Milada Šírová (7 shared papers)Onur Boyman (2 shared papers)Stacey N. Walters (2 shared papers)Shane T. Grey (2 shared papers)
- Journals
- Journal of Controlled Release (7 papers)Expert Review of Vaccines (3 papers)Value in Health (3 papers)Infectious Diseases and Therapy (2 papers)Bioconjugate Chemistry (1 paper)
- Partner nations
- CzechiaBelgiumUnited States
In The Last Decade
Tomáš Mrkvan
32 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 96
- Biomaterials 521
- Immunology 504
- Polymers and Plastics 181
- Transplantation 25
- Epidemiology 304
Countries citing papers authored by Tomáš Mrkvan
This map shows the geographic impact of Tomáš Mrkvan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomáš Mrkvan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomáš Mrkvan more than expected).
Fields of papers citing papers by Tomáš Mrkvan
This network shows the impact of papers produced by Tomáš Mrkvan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomáš Mrkvan. The network helps show where Tomáš Mrkvan may publish in the future.
Co-authors
The 25 scholars most cited alongside Tomáš Mrkvan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 431 | |
| 2 | 2008 | 110 | |
| 3 | 2008 | 109 | |
| 4 | 2008 | 83 | |
| 5 | 2009 | 80 | |
| 6 | 2006 | 78 | |
| 7 | 2017 | 77 | |
| 8 | 2018 | 77 | |
| 9 | 2005 | 60 | |
| 10 | 2007 | 55 | |
| 11 | 2006 | 54 | |
| 12 | 2009 | 49 | |
| 13 | 2009 | 44 | |
| 14 | 2003 | 44 | |
| 15 | 2017 | 43 | |
| 16 | 2017 | 40 | |
| 17 | 2004 | 38 | |
| 18 | 2019 | 36 | |
| 19 | 2020 | 32 | |
| 20 | 2014 | 31 |
About Tomáš Mrkvan
Tomáš Mrkvan is a scholar working on Epidemiology, Biomaterials, Molecular Biology, Oncology and Immunology, having authored 32 papers that have together received 1.7k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (10 papers), Herpesvirus Infections and Treatments (7 papers), Pneumonia and Respiratory Infections (5 papers), RNA Interference and Gene Delivery (5 papers), Immune Cell Function and Interaction (4 papers), Immunotherapy and Immune Responses (4 papers), Acne and Rosacea Treatments and Effects (3 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). The work is most often cited by research in Biomaterials (521 citations), Immunology (504 citations), Polymers and Plastics (181 citations), Transplantation (25 citations) and Epidemiology (304 citations). Tomáš Mrkvan has collaborated with scholars based in Czechia, Belgium and United States. Frequent co-authors include Blanka Řı́hová, Karel Ulbrich, Tomáš Etrych, Petr Chytil, Milada Šírová, Onur Boyman, Stacey N. Walters, Shane T. Grey, Rachel E. Kohler and Kylie E. Webster. Their work appears in journals such as Journal of Controlled Release, Expert Review of Vaccines, Value in Health, Infectious Diseases and Therapy and Bioconjugate Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.